|
||
|
| Home |  |
Firm Description | |
Sectors Covered | |
Completed Transactions | |
Testimonials | |
Principals | |
M&A Report and Publications |
|
Contact Us | |
| Acquiring Party | C. R. Bard, Inc. (NYSE: BCR), an international manufacturer of vascular, urology, oncology and surgical specialty products. |
|---|---|
| Transferring Party | Specialized Health Products International, Inc. (OTCBB: SHPI), a manufacturer of vascular access products. |
| Sector | Medical Devices |
| Date | June 5, 2008 |
| Analysis SHP's products are used to deliver therapeutic agents through vascular access ports and many are used to reduce the risk of accidental needlesticks. SHP is an original equipment supplier of winged infusion sets to Bard, and the deal gives Bard more control over the line. Deal value -- $68.4m, on 07 sales and EBITDA of $19m and EBITDA of $19m and $3.4m, respectively. | |
The Walden Group is a leading healthcare investment banking firm specializing in mergers, acquisitions and strategic transactions. It also invests its own funds and, together with its expert operational partners, provides value-added services to help special companies reach critical milestones. This information is copyright © 2004-2007 The Walden Group, Inc. This information is provided as a service to the public but remains the intellectual property of The Walden Group, Inc and may not be reproduced in any manner without the written permission of The Walden Group, Inc. The information contained in the transactions table was derived from publicly available and other sources. Transaction analysis and other information are based, in part, upon public comments, Walden Group research and judgments, and reporting and research of others. The information is not intended to be relied upon as pronouncements by the transaction participants or for any other reason. | |